LEADGENE SIDSCO BIOMEDICAL Co., Ltd.
Update：2026/11/10
Industries
Main Industry
Biotechnology
Main Product/Service
At LEADGENE SIDSCO BIOMEDICAL Co., Ltd., our primary business objective is to provide integrated contract research services. Based on the specific experimental requirements entrusted by our clients, we design a comprehensive experimental workflow and deliver complete experimental reports and results. We can establish and test dozens of different disease models on behalf of our clients, including cancer, viruses, bacteria, kidney diseases, osteoarthritis, and cardiovascular diseases.
The content above was translated by Ai
Founded Year
2018
Unified Business No.
42814106
Status
Active
Number of Employees
0
Total Paid-in
Capital
145,000,000 (NT$)
Location of Company
Taiwan
, Kaohsiung City
Exit Status
Acquired(2025)
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
LEADGENE SIDSCO BIOMEDICAL Co., Ltd. was established in 2018 and is stationed in the Innovation Incubator Center of Kaohsiung Medical University. Our company possesses a comprehensive contract research platform, which, at the cellular level, includes a viral infection platform, an antibacterial growth platform, an anti-inflammatory platform, and a cancer platform. For animal experiments, it also includes viral infection animal models, liver injury animal models, chronic kidney disease animal models, cancer animal models, and pneumonia animal models, among others. Our company also features a histopathology-related service platform that can provide clients with more precise analyses after animal experiments, as well as histopathological interpretations by professional veterinary pathologists.
The content above was translated by Ai
